Myeloma
Showing 26 - 50 of 133
Myeloma Trial in Rochester (Hyperbaric oxygen)
Recruiting
- Myeloma
- Hyperbaric oxygen
-
Rochester, New YorkJames P. Wilmot Cancer Center at University of Rochester Medical
May 5, 2022
Dual-Energy Computed Tomography for Improving Imaging Assessment
Not yet recruiting
- Myeloma
- Whole Body MRI
- (no location specified)
Apr 25, 2022
Myeloma, MGUS Trial in Rochester (Infusion of 13-Carbon labeled Glutamine)
Recruiting
- Myeloma
- MGUS
- Infusion of 13-Carbon labeled Glutamine
-
Rochester, MinnesotaMayo Clinic
Feb 10, 2022
Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)
Recruiting
- Lymphoma
- +2 more
- Kappa CD28 T cells
-
Houston, Texas
- +1 more
Jan 31, 2022
tHe Early Recognition of Febrile Neutropenia in Haematological
Recruiting
- Haematological Malignancy
- +4 more
- TempTraq temperature monitor
-
Wellington, New ZealandMalaghan Institute of Medical Research
Jan 10, 2022
Myeloma Trial in Sutton, London (Machine Learning (ML))
Active, not recruiting
- Myeloma
- Machine Learning (ML)
-
Sutton, Surrey, United Kingdom
- +2 more
Jan 7, 2022
Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloma Trial in Bergamo (Patient registry)
Recruiting
- Hodgkin Lymphoma
- +2 more
- Patient registry
-
Bergamo, ItalyHematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa G
Dec 22, 2021
Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)
Active, not recruiting
- Hodgkin's Lymphoma
- +17 more
- mycophenolate mofetil
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Dec 21, 2021
Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)
Active, not recruiting
- Myeloma
- Melphalan
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Dec 1, 2021
Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)
Not yet recruiting
- Monoclonal Gammopathy
- +2 more
- DKK1
-
Cleveland, Ohio
- +1 more
Nov 29, 2021
Myeloma Trial in Houston (drug, other, behavioral)
Completed
- Myeloma
- Minocycline
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 22, 2021
Hematologic Malignancy, MDS, Acute Myeloid Leukemia Trial in Providence (Transfusion support)
Recruiting
- Hematologic Malignancy
- +5 more
- Transfusion support
-
Providence, Rhode IslandRhode Island Hospital
Nov 4, 2021
Myeloma, Lymphoma, Autologous Transplant Trial in Angers, Le Mans (Adapted Physical Activity)
Recruiting
- Myeloma
- +2 more
- Adapted Physical Activity
-
Angers, France
- +1 more
Oct 7, 2021
Myeloma Trial in Netherlands (nivolumab-daratumumab, nivolumab-daratumumab with low-dose cyclophosphamide)
Active, not recruiting
- Myeloma
- nivolumab-daratumumab
- nivolumab-daratumumab with low-dose cyclophosphamide
-
Arnhem, Ge, Netherlands
- +8 more
Oct 5, 2021
Changing Over Time of Ascorbic Acid After Chemotherapy
Active, not recruiting
- Leukemia (Both ALL and AML)
- +2 more
- blood withdrawn
-
Maastricht, Limburg, NetherlandsMUMC+
Sep 23, 2021
Myeloma, Multiple Myeloma Trial in Chicago (Daratumumab, Carfilzomib, Lenalidomide)
Recruiting
- Myeloma
- Multiple Myeloma
- Daratumumab
- +3 more
-
Chicago, IllinoisThe University of Chicago
Sep 15, 2021
MRI in Multiple Myeloma: Analysis of Axial Skeleton Versus Whole
Terminated
- Myeloma
- MRI
-
Montpellier, France
- +1 more
Aug 3, 2021
Lymphoma, Myeloma, High-dose Chemo Trial in Berne (Pedometer-based activity monitoring after ASCT)
Recruiting
- Lymphoma
- +3 more
- Pedometer-based activity monitoring after ASCT
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Jul 29, 2021
Myeloma Trial in France (melphalan-prednisone-thalidomide, lenalidomide-dexamethasone)
Completed
- Myeloma
-
Albi, France
- +25 more
Mar 29, 2021
The Development and Pilot Testing ofNew MR Imaging Protocol to
Completed
- Myeloma
- +2 more
- Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
- +2 more
-
Oxford, Oxfordshire, United KingdomChurchill Hospital
Feb 4, 2021
Myeloma, Newly Diagnosed, High Risk Trial in GuangZhou (bortezomib, Lenalidomide, Dexamethasone)
Unknown status
- Myeloma
- +2 more
- bortezomib
- +2 more
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 15, 2020